Dr. Steven R. Mays, MD

Dr. Mays practices at Dsa Surgery Center in Bellaire, Texas.

Dr. Mays' NPI, 1942240031, was assigned on June 7, 2006. Dr. Mays graduated from Joe R. & Teresa Lozano Long School of Medicine in 1994. Dr. Mays holds Texas license J9907.

Dr. Mays' primary practice is Dsa Surgery Center, at 6700 W S Loop, Bellaire, TX 77401 in Harris County. The practice phone is (713) 791-9966.

Dr. Mays' primary practice is Dsa Surgery Center in Bellaire, Texas. Dr. Mays is also affiliated with Memorial Hermann-Texas Medical Center. The medical group on file is UT Physicians. Dmand AI also links Dr. Mays to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mays practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Mays' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Mays is board certified in dermatology by the American Board of Dermatology. Dr. Mays is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and minor injury to a limb among the conditions Dr. Mays treats.

CMS data shows 1,438 Medicare services from Dr. Mays across 13 procedure codes in 2024, for 507 Medicare patients. Medicare paid $68,234 for them. Every service was in an office.

CMS counts 507 Medicare patients who saw Dr. Mays in 2024. The largest group is 65 to 74, with 256 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mays' median patient age at 67, with 43% women.

In 2024, Dr. Mays wrote 1,350 Medicare Part D claims for 369 patients. 82% of them were for generic drugs. CMS names the drug for 1,157 of them, across 40 drugs with 11 or more claims each, at $760,919 in total drug cost. In 2023, CMS named 854 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mays for performance year 2024, reported as part of a group. Dr. Mays accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 403 procedures of removal of skin lesions by Dr. Mays, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Mays, published from 2014 to 2018. 2017 was the busiest year, with 3. The most frequent topics are Antineoplastic Agents, Dermatomycoses and Diagnosis, Differential. Dr. Mays has published most often in J Am Acad Dermatol. Dr. Mays' most frequent co-authors are Sirunya Silapunt, MD, Philip R. Cohen, MD and Madeleine Duvic, MD.

CMS Open Payments shows 136 general payments to Dr. Mays from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Janssen Pharmaceuticals, Inc paid the most, $662.

Dr. Mays graduated from Joe R. & Teresa Lozano Long School of Medicine in 1994.

Dr. Mays is in network with 19 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.